Jan Dutz, MD, FRCPC - Clinical Updates on Targeting IL-17 in Rheumatic Diseases: Striking at the Heart of Inflammatory Processes in PsA and axSpA

What this episode covers

Visit https://www.peervoice.com/YBG860 to view the entire programme with slides. After completing “Jan Dutz, MD, FRCPC - Clinical Updates on Targeting IL-17 in Rheumatic Diseases: Striking at the Heart of Inflammatory Processes in PsA and axSpA”, participants will be able to: Discuss unmet needs in the management of patients with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA); Evaluate the evidence with new targeted therapies for PsA and axSpA; and Outline the clinical implications with new therapies for the management of patients with PsA and axSpA.

Distinct summary based on available episode metadata or transcript content.